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SUMMARY:  Nucleic acid aptamers have found steadily increased utility and application steadily over
the last decade. In particular, aptamers have been touted as a valuable complement to and in some cases 
replacement for antibodies due to their structural and functional robustness as well as their ease in 
generation and synthesis. They are thus attractive for biosecurity applications, e.g. pathogen detection,
and are especially well suited since their in vitro generation process does not require infection of any host 
systems.  Herein we provide a brief overview of the aptamers generated against biopathogens over the last 
few years. In addition, a few recently described detection platforms using aptamers (aptasensors) and 
potentially suitable for biosecurity applications will be discussed.
INTRODUCTION
Biosecurity refers to the policies and procedures designed to prevent the deliberate theft or 
diversion of deadly pathogens and toxins for malicious or criminal purposes. While the goal is clearly to 
prevent any such criminal act, crucial in an effective response to a bioterrorism attack will be the 
swiftness and accuracy in both medical and environmental detection and characterization of the 
threat.[1,2] Even though great strides have been achieved in the environmental surveillance of potential 
biothreat agents, technologies needed for fabricating efficient, portable, fieldable and highly robust 
biopathogen sensors largely remain.[3,4]  Many of the existing pathogen-sensing devices utilize
antibodies as molecular recognition elements that mediate some signal transduction indicating the 
presence of the pathogen.  However antibodies are limited by their structural robustness when exposed to 
varying temperatures and humidity and there remains an unfulfilled need in generating and producing all 
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of the antibodies required against the myriad types of biothreats and the especially high affinity
monoclonal antibodies.
With these limitations, nucleic acid aptamers (target binding sequences generated through 
reiterative partitioning and selection process known as SELEX [5,6]) have recently been touted as 
valuable complements and in some cases potential antibody replacements due to their structural 
robustness and their ease in generation, synthesis and modification.[7,8] In addition, nucleic acid 
aptamers have become especially attractive as their generation process is not in vivo, but rather in vitro
and no exposure to a host system is required.
Over the years, nucleic acid aptamers have been generated against a range of targets and adapted 
for numerous chemical or biological sensing systems.  It is not the intent of this review to provide an 
exhaustive compilation of all these entries. Rather, a few recent examples that highlight the applications 
and utilities of the nucleic acid aptamers toward biosecurity applications will be described.
APTAMERS AS BIOTHREAT PATHOGEN SENSING LIGANDS
Even with their efficient generation process, aptamers are significantly less developed compared 
to antibodies against biothreat-relevant agents. In recent years, there have been intermittent reports in 
which aptamers have been generated against potential biothreat agents.  Both the Center for Disease 
Control (CDC; www.bt.cdc.gov/bioterrorism/) and the National Institute of Allergy and Infectious 
Disease (NIAID; www3.niaid.nih.gov/Biodefense/PDF/cat.pdf) have published a list of priority pathogens 
(Category A to C), with Cat-A being the highest priority in term of their threats to national health and 
security. A brief survey of the biothreat agents and the availability of aptamers that have been generated 
against these targets follows. 
Bacillus anthracis spores (Cat-A pathogen).  The anthrax (bacillus anthracis) spore incident
after 9/11 illustrates the simple fact that microorganisms can be disseminated to not only cause infection,
but perhaps more damagingly, inflict fear and panic in the general public.  Thus, increasing attention and 
resources have been since focused for rapid pathogen detection and characterization. B. anthracis are 
gram positive, soil-borne bacteria, endemic to many regions in the US and around the world with  ~90
bacillus strains having been reported to date. Most of these strains do not pose any great threat however, 
among, the most virulent strain is the Ames strain (used in the postal attack) while the Vollum strain has 
been deemed most suitable for bioweaponization. As the bacteria are able to reside dormant in the soil 
and other media as endospores (spores), they can survive for a long period under varying environmental 
conditions.  When inhaled and/or accidentally consumed, the bacteria can rapidly multiply in their host 
animal, ultimately killing it.  It is also noted that as they are able to replicate in carcasses, humans can 
also get infected when they are exposed to the infected animal tissues.
In an attempt to develop alternatives to antibody affinity reagents, ssDNA aptamers generated 
against autoclaved bacillus spores derived from stern strain were first described by Bruno and Kiel in the 
late 1990s.[9] The authors utilized centrifugation for partitioning the unbound DNA sequences from the
DNA-spore complexes. Bruno and Kiel used both an aptamer-magnetic bead-electrochemiluminescence 
sandwich assay and a colorimetric assay to demonstrate binding to the anthrax spore target and 
established a wide dynamic range from <10- >6 x 106 anthrax spores. However, the spore-binding DNA 
aptamer sequences and their respective affinities were not reported limiting the utility of this report to 
serve as the basis of optimizing these aptamers or applying them to other sensing platforms.
A similar set of experiments was recently undertaken by Yang and coworkers, in which DNA 
aptamers were generated against spores of b. anthracis vaccine strain A 16R.[10] A total of 15 selection 
rounds were performed with a starting ssDNA library that contains a 35 nt randomized region. DNA that 
was bound to the bacterial spores was separated by centrifugation and amplified via PCR. At the end of 
the selection cycles, the remaining DNA was cloned and sequenced. Among the obtained sequences, one 
full length 78nt aptamer (Apt1) was resynthesized and employed as a molecular recognition element 
(MRE) in a membrane-based hybrid sandwich assay. The assay is essentially comprised of an anti-spore 
antibody and labeled aptamer. Via this assay, it was observed that a ratio of 16 mg of Apt1 was able to 
detect ~4 x 107 spores, with the dynamic range from 4 x 107 to 4 x 104. Upon further minimization 
studies, it was realized that the aptamer, Apt2 (32nt), had the best binding affinities compared to other 
sequences studied. Upon further minimization to Apt3 (27nt), the binding effect was almost abolished, 
showing that the seemingly unstructured ssDNA tail was also important for spore binding. The secondary 
structures for all the studied anti-spore aptamers are predicted by the Mfold program,[11] and are shown 
in Fig. 1A.
Influenza Virus (Cat-C pathogen). Influenza, commonly known as flu, is caused by a RNA-
based virus that belongs to the Orthomyxoviridae family. The virus can easily be transmitted via bodily 
fluids or through the air from infected individuals. In the case of animals or birds, transmissions usually 
occur through their droppings. Influenza has resulted in widespread disease and considerable death for 
centuries, with pandemics occurring in the last century approximately every 20 to 30 years Of recent 
concern is a deadly strain of avian influenza, H5N1, that is highly lethal to humans but because it is not 
easily transmitted between humans has only resulted in ~100 human fatalities.[12] However, a mutation 
to this H5N1 stain could result in a strain that is more easily transmitted among human hosts thus 
surveillance of the existing disease as well as indications of any mutated forms is of high priority.. 
Hemagglutinin (HA) and neuraminidase (NA) are two major glycoproteins present on the surface 
of the influenza virus envelope. Through HA, the virus is able to bind to sialic acid-modified receptors on 
host cells, and thus initiate viral infection by facilitating viral entry. Flu surveillance makes it essential 
that the various subtypes and even closely related viral strains can be accurately determined in a timely 
manner. Complicating this task is the fact that the HA and NA proteins on the surface of the influenza 
virus are able to undergo rapid mutation from generation to generation,. These mutations have also made 
the vaccine generation process against the virus much more difficult.
In the first of a series of approaches to generating aptamers against the HA protein, Kumar and
co-workers utilized the surface plasmon resonance (SPR) technique to isolate RNA aptamers against
purified HA of human A influenza virus, subtype H3N2.[13] This novel approach conveniently allowed 
for both the simultaneous monitoring and binding of the aptamers to the HA target. In a subsequent 
report, the same group selected RNA aptamers against whole H3N2 virus particles. The anti-HA RNA 
aptamers obtained displayed remarkable specificity as they were shown to differentiate HA proteins from 
closely related H3N2 strains.[14] After analyzing the sequences obtained after 10 selection cycles
(partitioning via nitrocellulose filters), the highest HA binding aptamer (Apt4, structure shown in Fig. 
1B) showed a Kd of ~188 pM as measured via SPR, which was ~15-fold higher than the existing anti-HA 
monoclonal antibody (Kd of ~2.9 nM).  From sequence analysis of multiple clones a consensus sequences 
was identified as 5’-GUCGNC(X)4-5GUA-3’, in which “X’ can be any bases. Interestingly, the aptamer 
was observed to be able to inhibit the HA-mediated membrane fusion process, which greatly underscores 
its potential application as anti-influenza therapeutics. In another separate report, the same group has also 
utilized the same selection approach to generate RNA aptamers against the HA of human influenza B (a 
total of 9 selection cycles performed).[15] Among the obtained sequences, one of the aptamer was 
observed to demonstrate high selectivity as it is able to differentiate between the HA from influenza A 
and B viruses. Again via SPR, its Kd was measured to be ~720 pM and, similar to human influenza A, the 
generated RNA aptamer is observed to be able to inhibit HA-mediated membrane fusion process for 
human influenza B.
Instead of using RNA aptamers, Arnon and co-workers have shown that DNA aptamers can also 
be efficiently evolved against a specific domain of HA from influenza A virus.[16] By simply expressing 
a specific His-tagged oligosaccharide receptor domain (amino acids 91-261) of the HA and subjecting to 
the SELEX process via affinity partitioning approach, selected anti-HA ssDNA aptamer (Apt5, structure 
shown in Fig. 1B). Isolated after only 4 selection cycles, Apt5 was observed to be able to prevent HA 
docking onto cell receptors. Thus, both DNA and RNA-based aptamers can be employed as inhibitors for 
influenza viral infectivity and have the potential to not only be detection reagents but also therapeutics.
Francisella tularensis (Tularemia, Cat-A pathogen).  Commonly referred to as “rabbit fever”, 
“deer-fly fever” and “market men’s disease”, Tularemia is often considered to be one of the most 
infectious bacterial diseases. The bacteria responsible for the disease are known as Francisella tularensis
and is endemic to many/all parts of the US.  It usually resides in ticks and deer flies, and is transmitted to 
humans through their bite wounds. The bacteria primarily infect and reside in the host’s white blood cells, 
and are able to evade the immune system. At an opportunistic moment, the bacteria will begin its
replication cycle and subsequently invade other organs throughout the body. Upon the failure of major
human organs, fatality occurs. Its high degree of infectivity is illustrated by observations that as few as 10 
organisms are able to cause tularemia in humans. F. tularensis has four subspecies, in which only the 
tularensis and holarctica are pathogenic to human. 
Isolation of DNA aptamers that specifically binds F. tularensis was recently reported by 
Vivekananda and Kiel.[17] The authors utilized nitrocellulose (NC) filter binding for partitioning the 
bacteria-bound DNA complexes with a total of 10 selection cycles were performed. By using both a 
sandwich aptamer-linked immobilized sorbent assay and a dot blot analysis, the authors observed that the 
anti-tularemia ssDNA aptamers, as a cocktail of 25 unique DNA sequences from the selection, were able 
to specifically bind the antigens from both holarctica and tularensis subspecies. The DNA aptamers also 
demonstarted high selectivity as they did not bind to either pure chicken albumin or chicken lysozyme. 
However, the binding sequences and their affinity studies were not reported limiting the further 
characterization of these aptamers or their use in other sensing platforms.
Ricin Toxin (Cat-B pathogen). Ricin is a toxic protein isolated from the seeds of castor bean 
plant, Ricinus communis. Ricin is extremely poisonous with reports that 0.2 mg of the toxic protein is 
sufficient to kill an adult. Since the castor bean plant can easily be cultivated, ricin can be purified and 
generated without the need of complicated laboratory equipments. The ability to develop an efficient, 
rapid and accurate sensing system for ricin is thus essential. The ricin protein is comprised of two main 
domains, namely the A-chain and B-chain.  The two domains are simply linked to each other via a 
disulfide bond. The primary role of the ricin B-chain serves to assist the A-chain to gain entry to targets 
cells, thus the B-chain is not toxic by itself.  However, once inside the cell the A-chain is extremely toxic
as it disrupts the protein synthesis process by targeting the ribosomal RNA.
Hesselberth and co-workers have shown RNA aptamers can be selected against the ricin A-chain 
with high affintiy and specificity.[18] The RNA aptamers were generated via 9 selection cycles using the 
NC filter partitioning approach. Upon analysis of the obtained selected aptamers, it was observed that the 
sequences bear no resemblance to its usual target ribomsal RNA substrate. To understand the necessary 
conserved region that is responsible for ricin A-chain binding, the aptamer was further minimized to 31nt
without any loss in binding affinity. Upon using the Mfold secondary structure prediction software, the 
short 31nt aptamer stretch was still able to adopt the putative necessary secondary structure, and exhibited
a Kd of 7.3 nM against the A-chain.  
Instead of targeting the ricin A-chain domain, Tang and co-workers have proceeded to purify the 
whole intact ricin protein from decorticated castor beans. The intact ricin protein was susbequently 
utilized as a target for ssDNA aptamer generation.[19] Anti-ricin DNA aptamers were partioned in two 
ways, namely through traditional affinity chromatography and capillary electrophoresis (CE). The main 
advantage of CE is the efficiency needed to generate the high affinity aptamers as generally only ~4 
rounds of selection cycles is required (Bowser refernces would be good here), whereas using traditional 
affinity chromatography ~8 or more selection cycles are usually required. Upon completeion of the 
selection cycles via both approcahes and surveying the binding affinities of individual aptamers from each 
selection approach, it was observed that the aptamers derived from affinity chromatography possesses Kds
in the 105-514 nM range, whereas CE-derived aptamers have Kds from 58-195 nM. These observations
suggest CE-SELEX can increase selection efficiency for higher affinity aptamers. 
Trypanosomes-Alder Protozoa (Cat-B pathogen and its simulants).  Protozoa are defined as 
single-celled eukaryotes and are generally considered to be the “smallest of all animals”. However, 
certain parasitic protozoans are extremely infectious and they pose a serious threat to humans. For 
example, Cryptosporidium parvum is a water-borne protozoan parasite that results in disease manifested 
through a lengthy period of symptoms such as watery diarrhea, cramps, nausea and anorexia. Another 
related protozoic parasite that has been garnering a lot of attention lately is the Trypanosomes. 
Trypanosomes are ubiquitous parasites of numerous hosts and have both threatened and claimed the lives 
of numerous humans, cattle, and other domesticated animals throughout Africa and South America in 
recent decades. Trypanosome infections are invariably fatal, and it could take weeks to years for them to 
exert their pathogenicity depending upon the species and the virulence of individual strains. These blood 
parasites are the main etiological agents for diseases such as Sleeping sickness (T. brucei) and Chagas’s 
disease (T. cruzi). Although Trypanosomes are not listed in the NIAID priority list, the protozoa are 
nonetheless highly pathogenic and are considered to be viable simulants for all protozoic parasites.
Goringer and co-workers have been investigating the generation and application of RNA 
aptamers as potential therapeutic tools against T. brucei in recent years,[20,21] and they have successfully 
generated three distinct classes of RNA aptamers against live T. brucei.[22] It was observed that the RNA 
aptamers are able to cross link to a single 42 kDa protein located within the flagellar pocket of the T. 
brucei parasites, suggesting the potential binding site for the aptamers. Interestingly, the aptamers were 
not able to discriminate other strains of Trypanosomes, implying that the aptamers could thus function as 
general “markers” on the surface for these extracellular parasites. More importantly, they could also 
function as therapeutic agents against most strains of trypanosomes. The same group has recently 
generated a 2’-NH2-modified RNA aptamer that binds live trypanosomes with an affinity of ~70 
nM.[23] It was observed (or hypothesized?) that this aptamer adopts a G-quartet structure upon target 
binding and due to its structural modifications, it is stable in human serum of ≥30 hrs.  Again, the site of 
RNA aptamer binding was observed to be in the flagella attachment zone.
Beside T. brucei, Ulrich and co-workers have recently reported the generation of RNA aptamers 
against the cell adhesion receptors of T. cruzi.[24] The cell adhesion receptors consist of a matrix of host 
cell proteins which include fibronectin, laminin, thrombospondin and heparin sulfate. Using 
centrifugation for partitioning the RNA-protozoa complexes, the pool of aptamers generated after 7
selection cycles (via targets displacement) are observed to have an overall Kd of ~170 nM. More 
importantly, a few of selected aptamers are also observed to be active in vitro inhibitors for the T. cruzi
invasion process against monkey kidney cells.
Salmonella Typhi (Cat-B pathogen).  Besides anthrax dissemination via the mail, the only other
documented incident of bioterrorism attack occurred in the state of Oregon in the mid 1980s. Executed by 
members of the Rajneeshee cult, with the main motive being trying to affect the outcome of a local 
election, restaurant salad bars were intentionally contaminated with salmonella bacteria. Although no 
fatalities resulted from this episode, it highlights the fact that these biothreat agents can be easily 
disseminated to inflict widespread panic and potential financial losses to targeted communities and/or 
nations. Salmonella are rod-shaped, gram-negative bacteria in which many sub-species exist.  In general, 
salmonella is a foodborne illness. For example, typhoid fever is a serious illness caused by Salmonella 
typhi. Typhoid fever usually occurs in countries that lack clean water and basic hygienic practices. The 
bacteria are found in human excrement, and can be easily transmitted via contaminated water or food.
Thus their rapid detection and identification is highly desired.[25]
Pili are hollow, hairline structures that enable bacterial attachment. It was observed that when 
mutations are introduced to the gene that encodes the pili (pilS) in S. typhi, their ability to adhere and 
invade human gastrointestinal epithelial cells in vitro was drastically reduced.[26] This suggests that the 
structural protein PilS may have important roles in the pathogenesis of S. Typhi in humans.  Pan and 
coworkers have recently reported the generation of RNA aptamers against the type IVB pili of S. Typhi, 
which is composed largely of polymerized PilS protein.[27] After 8 rounds of selection cycles, the anti-
pili aptamers obtained are observed to bind the PilS protein with a Kd of ~7 nM. In specific, consensus 
sequences (present eight times in the 14 clones studied) within individual RNA aptamers was AGCG-(X)-
GG, in which “X” is any nucleotides. The secondary structure of the consensus sequences, after modeling
studies, is anticipated to exist as a “stem-loop”. 
APTASENSING PLATFORMS AND DETECTION ASSAYS
Advances in automated protein production techniques has fueled the widespread utility and 
application of protein-based microarrays.[28] One main drawback of the protein microarray chip is that 
the immobilized protein may denature through structural rearrangement. To confer structural robustness 
in the molecular recognition elements suited for the planar microarray sensing platform, aptamers have
successfully been demonstrated as the next viable option in recent years.[29,30] Ellington and co-
workers, have pioneered the design and fabrication of aptamer microarrays,[31-33] in which the group 
has enabled an automated protocol for aptamer generation.. It is projected that with the augment of 
automated SELEX selection process, nucleic acid aptamers can now be generated in days, rather than 
weeks to months. 
Instead of a planar platform, suspended encoded beads have gained popularity as of late since the 
beads can be rapid decoded to render interaction information.[34] Furthermore, the beads can be 
engineered such that they are easily manipulated by either magnetic forces or electric field. For example, 
Luminex Corp (Austin, TX; www.luminexcorp.com) has manufactured polystyrene beads which are 
injected with different ratios of fluorescent dyes.  Each bead is thus conferred a unique spectral 
characteristic, and the beads can be subjected to multiplex interrogation since each interacting event on 
individual beads can efficiently be sorted via flow cytometry and rapidly decoded. Recently, Luminex 
beads have been conjugated with various antibodies for sensing biowarfare pathogenic simulants, e.g. 
plague, anthrax.[35] In addition, aptamers have successfully been used by Porschewski and co-workers as 
antibody replacements using Luminex beads as platforms.[36] Aside from polystyrene beads, Fan and co-
workers have reported the use of dielectric microsphere as aptamer sensing platform.[37] Dielectric 
microspheres support a series of optical resonance modes at the surface called whispering gallery modes. 
By attaching anti-thrombin aptamers onto the microspheres, it was observed that the thrombin protein can 
be detected with a detection limit of 1 NIH unit/mL. 
Depending on their aggregation state, nanoparticles (NP) have been reported to enable different 
color emission. Taking advantage of this observation, Liu and Lu have described a novel strategy for an
aptamer-mediated colorimetric sensor based on the dissolution of a NP aggregate (Fig. 2A).[38]
Initially, the colorimetric aptamer-based sensor is an aggregated complex comprised of AuNPs, aptamers
and oligonucleotide linkers. The oligonucleotide sequences utilized in this study are comprised of anti-
adenosine or anti-cocaine aptamer sequences. Upon the addition of their small molecule targets, the 
aptamers are able to undergo a structure switching process to enable tight binding to its small molecule 
target. This results in the displacement of an AuNP-conjugated complementary strand, thus causing the 
overall AuNP deaggregation process. Consequently, a visible color change ensues due to changes in both 
the color and extinction of the AuNP..
Based on the same principle, Huang and co-workers have described a colorimetric approach for a 
protein detection sensing system.[39] In the presence of platelet-derived growth factor (PDGF) protein 
targets, the aptamer-AuNP system begins to aggregate. Subsequently, changes to both the color and 
extinction of the AuNP, due to changes in aggregation states, can be monitored in real time (Fig. 2B). The 
color of the AuNP was observed to change from red to purple when low PDGF protein concentration 
(<400 nM) is added.
Instead of using AuNP, Ellington and co-workers have utilized quantum dots (QD) as platforms 
for aptamer-based detection.[40] An anti-thrombin aptamer was first hybridized with a short quencher 
oligonucleotide labeled with a quencher dye, followed by immobilization onto the QDs. Since the 
quencher dye is in close proximity to the QD, its emission is quenched (Fig. 2C). In the presence of the 
thrombin target, the aptamer undergoes a structural change to accommodate the thrombin target, 
displacing the quencher oligonucleotide. The release of the quencher from the QD surface restores the 
original QD emission profile. Another noted advantage is the QDs have tuneable wavelength emissions.
Thus, by attaching different aptamer constructs onto different quantum dots in a heterogeneous solution, 
multiplex interrogation of numerous target molecules is feasible.
Several elegant bioelectronics sensing systems have been described by Willner and co-workers 
over the last few years. Of particular interest is a recent aptamer-based bioreadout enhancement process 
that involves the catalytic enlargement of AuNPs (Fig. 3).[41] Anti-thrombin aptamers were first
immobilized onto glass substrate surfaces to capture the thrombin target. An aptamer-based sandwich 
complex was the formed in the presence of thrombin by the addition of AuNP-labeled aptamers. The 
AuNP were then catalytically enlarged in a solution mixture containing HAuCl4. By increasing the 
effective size of the AuNPs in this manner, the AuNP coupled plasmon absorbance at 650 nm was 
enhanced and could be efficiently measured. The sensitivity for thrombin detection was observed to be 
~20 nM, approximately five-fold better than colorimetric detection via organic polymer chromophores.
In another novel extension involving the application of the aptamer displacement detection 
strategy, Willner and co-workers have developed a label free, reagentless Ion-Sensitive Field Effect 
Transistor (ISFET) aptamer-based sensing device.[42] Upon binding to adenosine monophosphate 
(AMP), an AMP aptamer releases a hybridized short complementary oligonucleotide, which in turn
affects the charges associated with the gate and alters the source-to-drain current (Fig. 4). This approach 
demonstrated a sensitivity limit of  5 x 10-5 M, requiring only a 4 min response time.  The sensing system 
was also highly specific as other monophosphates, e.g CMP, GMP and TMP, did not result in changes to 
the ISFET potential. The reported sensitivity represents a 10-fold enhancement over currently available 
colorimetric or electrical aptamer-based sensing systems.
Another label-free impedance spectroscopy bioelectronic detection assay was recently reported 
by Wang and co-workers, in which the binding event is reflected through changes in charges of the 
electrode’s surfaces.[43] Specifically, anti-lysozyme aptamers were first conjugated onto Indium Tin 
Oxide electrode transducers. Negatively charged [Fe(CN)6]3-/4- was used as a marker, and in the absence 
of protein target, the marker is repelled from the surface. However upon protein binding, the negatively 
charged marker is attracted to the electrode surface, subsequently increasing the electron transfer from the 
marker to the electrode. Besides the detection assay high sensitivity (~140 fmole of lysozyme target in 10 
mL sample volume), the assay is also highly specific as addition of non-binding proteins such as 
thrombin, cytochrome C and albumin do not affect the electron transfer resistance of [Fe(CN)6]3-/4-.
To enable multiplexed detection via electrochemical aptamer biosensors, Hansen and co-workers 
have reported the usage of a variety of distinct inorganic QD tracers as aptamer labeling reagents.[44] It 
was observed that both Cd2+ and Pb2+-based QDs possess excellent coding and amplification features. 
Hence via the single step displacement assay and subsequent application of electrochemical stripping 
detection of the QD tracers, the obtained detection sensitivity was observed to be in the sub-pM range
(Fig. 5). Although only 2 analytes were used in the study, this approach can be readily expanded for 
multiplexed target interrogation by encompassing other types of QD tracers.
Most aptamers, such as thrombin-binding ssDNA, usually undergo some form of structural
rearrangement (or folding process) upon target binding.  Plaxco and co-workers have recently described 
an electronic aptamer-based (EAB) sensing system in which by tethering a redox probe, e.g. methylene 
blue, at the end of the aptamer, the resulting folded aptamer-protein complex is able to render the redox 
probe in close proximity to the Au-surface (Fig. 6).[45,46] This results in an electron transfer between 
the redox probes to the Au surface and thus the resulting electrochemical change indicates a positive 
binding event. With the ability to rapidly fabricate the aptamers in an array format, a multiplex pathogen 
sensing aptamer-based microarray chip can be envisioned for their rapid identification and/or 
characterization.
Tan and co-workers have engineered light-switching excimer probes for rapid and sensitive 
detection of the PDGF protein.[47] Labeled with one pyrene at each end of the aptamer, the binding of 
the protein target brings the two pyrene molecules in close proximity to eachother. The resulting shift in 
the fluorescence emission from 400 nm (pyrene monomer) to 485 nm (pyrene excimer) can be monitored 
in biological fluids using both steady-state and time-resolved fluorescence measurements (Fig. 7A). Thus, 
this approach is ideally suited for protein function studies in both intracellular or intercellular 
environments. Since the described excimer signal approach requires its target molecule to be present to 
induce structure switching, sample pre-treatment and false signals caused by nucleases degradation and/or 
nonspecific binding are both eliminated.
Using a similar “bind and read” approach, Li and co-workers have also described the application 
of FRET-based optical readout when the DNA aptamer undergoes a structural arrangement upon target 
binding.[48,49]  Briefly, a 3-piece DNA sandwich was first formed to bring a fluorophore-labeled DNA 
oligonucleotide (F-DNA) in close proximity to a quencher oligonucleotide (Q-DNA). In the presence of
the target molecule, the unmodified oligonucleotide (MAP), which contains the target binding aptamer 
sequences, will fold to enable tight binding to its target (Fig. 7B). The structural arrangement of the 
aptamer will result in the displacement of the Q-DNA, which then restores the fluorescence signal. 
Aptasensors that are able to channel recognition events into fluorescence changes are of great 
interest as they are “reagentless” and easy to operate. Taking advantage of allosteric regulation of non-
covalent interactions with fluorophores, Stojanovic and Kolpashchikov have recently designed RNA 
aptamers which contain both recognition and signaling domains, i.e. able to bind to both fluorophores and 
small molecule targets. [50]  When both fluorophores (e.g., malachite green) and small molecule targets 
(ATP) bind to their respective domains, the overall effect is the generation of an enhanced fluorescence 
emission. These aptamers are termed “modular aptameric sensors.” It was observed through a series of 
mutation investigations of the communication module stem constructs, that certain aptamer structures, are 
able to demonstrate fluorescence increases of 3- and 4-fold, respectively, when 1 mM of ATP was added.  
Hence, should such modular aptameric sensors be expressed in cells, they could be utilized for 
intracellular imaging.
Along the same “bind and read” aptamer-based fluorescence reporter concept, another novel 
entry was recently reported by Katilius and co-workers, in which direct bioreadout aptamer-based sensors 
were designed by strategically positioning fluorescently-modified nucleotides in the sensing aptamer so 
that the fluorescent nucleotides are in close proximity to the target binding site.[51] The single position 
in the aptamer for substitution, which can undergo base-stacking changes upon binding to its target, are
identified through both computational and structural examinations. The resulting structural rearrangement 
of the aptamer binding site subsequently effects a fluorescent signal change. For example, based on 
computational analysis, thymine in position-7 of the anti-thrombin binding aptamer was systematically 
replaced with fluorescent base analogues. It was observed that specific base analogue such as 6MAP has
the greatest effect, in which the relative increase in fluorescence between the bound and unbound states of 
the aptamers is ~30-fold.
A novel approach for analyzing the aptamer interaction through a “exonuclease protection” assay
was recently reported Xu and co-workers.[52]  Upon binding of the aptamer to its protein target, the 
protein is able to protect the aptamer from exonuclease I degradation. The remaining aptamer fragment 
functioned as a linker to join two complementary oligomeric sequences, in which the joined products 
were subsequently amplified by PCR. Exquisite sensitivities were achieved via this approach as the 
number of protein targets detected was on the order of 102. Furthermore, the assay offers an excellent 
detection range, encompassing 7 orders of magnitude. 
The use of CE to efficiently isolate and/or detect DNA aptamer-protein complexes has been 
described in recent years.[53,54] These approaches have enabled the aptamer generation process to be 
more expeditious as the partitioning efficiency of CE is high (~104). Hence, very low levels of protein 
targets, to which aptamers are bound, can be isolated. Zhang and co-workers have described the 
application of CE to isolate the protein-aptamer complex, using PCR amplification of the DNA aptamer 
to enable high protein detection sensitivity.[55]  It was reported that as few as 6 aptamer molecules are 
needed for target detection. In addition, Collins and coworkers have also utilized Laser Induced 
Fluorescence-CE to enable direct detection of sub-nM concentrations of ricin A-chain with fluorescently-
labeled aptamers.[56] When performed in a free-solution assay, a detection limit of 500 pM was achieved, 
and the presence of other proteins such as BSA, casein and RNA nucleases did not interfere with the 
aptamer’s specificity.
CONCLUSION AND FUTURE DIRECTIONS 
In 2003, it was reported in the Washington Times that documents seized from a high-ranking Al 
Qaeda member revealed that a Pakistani microbiologist was recruited by the organization with the intent 
to manufacture both botulinum toxins and anthrax spores. This clearly illustrates that the threat of 
bioterrorism, which was once considered to be simply a hypothetical threat, is a clear and present 
one.[3,57] Primarily due to the ease in the DNA aptamers generation and/or selection process, the low
cost of synthesis, and their structural stability, DNA aptamer have evolved to hold great promises as a 
potential source of sensing ligands for employment in biosensing systems. Although there are still certain 
limitations to their use, as the general binding affinities of nucleic acid aptamers still do not rival those of 
monoclonal antibodies, it is evident that the wealth of biorecognition approaches reported in this review 
hold great promise. Nonetheless, a huge disconnect remains in the successful translation of most of these 
technologies to be implement in actual product fabrication. With the rapid advances in both aptamer 
generation against biopathogenic targets and their corresponding bioreadout processes and platforms, it is 
thus forecasted, with great anticipation, that greater symbiotic relationship with the advent of micro- and
nano-engineering will soon enable fieldable, accurate and, perhaps, even implantable multiplexed 
pathogen aptasensors. 
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Annotations:
 3. An exhaustive review paper which provides readers an excellent understanding of the various 
advances in monitoring biowarfare agents.
 12. The article describes the generation of RNA aptamers against whole viruses. The RNA aptamer 
analyzed have remarkable affinity (as it is ~15-fold higher that monoclonal antibody) and selectivity (able 
to differentiate the same protein (HA) form different viral strains. The aptamer is also observed to be able 
to prevent the binding of the virus to targeted cells in vitro.
 20. This article describes the application of two approaches, namely CE and affinity chromatography, 
to generate DNA aptamers against whole Ricin protein. Through the CE approach, it was observed that 
the aptamers generated have higher affinities against the Ricin target and is faster to generate.
 24. This article describes the generation of 2’-NH2 modified RNA aptamers against live 
Trypanosomes protozoa. The aptamers are observed to be stable in human serum for over 30 hours, 
highlighting their structural robustness and their potential application as MREs in sensing system.
 35. An overall concise, yet comprehensive, review paper detailing the latest advances in encoded 
particles. Enhancing information derived from these encoded particles would greatly facilitate the 
multiplex targets detection and characterization.
 39. The article describes the application of AuNP-aggregate, via aptamer and complementary 
oligonucleotides, for small molecule detection. The de-aggregation process, due to displacement of 
“linking” complementary oligonucleotides, results in visible colorimetric changes.
 47. The article describes the development of electronic aptamer-based (EAB) sensing system based on 
the displacement of complementary oligonucleotides. The attachment of redox probe at the end of 
aptamer will then be able to allow electron transfer.
 49. The article describes the novel design of pyrene end-labeled aptamer that is able to shift its 
fluorescence emission, upon target binding, through excimer formation. The excimer’s long fluorescence 
lifetime suppresses the background signals, making the assay adaptable for most test mediums.
 53. The article describes the strategic incorporation of fluorescent nucleotide analogues to existing 
signaling aptamer such that fluorescence enhancement up to 30-fold can be achieved upon target binding.
 57. The article describes the application of CE to first isolate target bound reporter DNA aptamer. 
Subsequent PCR amplification of reporter aptamer enables ultrasensitive determination of target protein
FIGURES:
Figure 1. [A] Secondary structures of studied DNA sequences against b. anthracis spores, as predicted by 
the Mfold program.[9] (i) Full-length 78nt Apt1 binding aptamer, (ii) a minimized 32nt Apt2 binding 
aptamer from a different sequence, (iii) further minimization of Apt2 to a 17nt Apt3 aptamer abolished 
its binding affinities, showing that the predicted single stranded region is also important for spore binding. 
[B] Secondary structures, aspredicted by the Mfold program,[10] of (i) RNA sequences against the HA of 
Human influenza A and (ii) DNA sequences against the HA (aa 91-261) of the Influenza A virus.
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Figure 2. [A] Colorimetric detection of cocaine based on cocaine-induced disassembly of NP aggregates 
linked by a cocaine aptamer. Folding of the anti-cocaine aptamer displaces the AuNP-conjugated reporter 
oligonucleotide, thus resulting in the deaggregation of the AuNP.[39] [B] With increasing PDGF protein 
target concentrations, different degrees of AuNP aggregation are obtained, . resulting in different 
colorimetric changes, e.g. red to purple.[40] [C] (i) QD-aptamer beacon for the detection of thrombin 
target proteins. (ii) Binding of protein targets displaces the quencher oligonucleotide and enhances the 











Figure 3. Amplified detection of thrombin on surfaces by the catalytic enlargement of AuNPs 
functionalized with anti-thrombin aptamers . [43]
Figure 4. Schematic of a label-free, reagentless ISFET aptasensor device for small molecule (adenosine) 
detection.[44] The release of the short complementary oligonucleotide will then affect the charges 
associated with the gate, thus altering the source-to-drain current.
Figure 5. [A] A dual analyte aptamer-based biosensor involving the displacement of QD-tagged proteins 
by the target analytes.[46] Briefly, the QDs on the displaced tagged proteins are subjected to 
electrochemical-stripping detection at a coated glassy carbon electrode. [B] Schematic illustration of 
label-free protein detection via monitoring changes in electron transfer through negatively charged 
[Fe(CN)6]3-/4- markers. [45]
[A] [B]
Figure 6. Schematic illustration of the electronic aptamer-based (EAB) sensing system. [47]
Figure 7. [A] Schematic illustration of the pyrene end-labeled excimer to detect the PDGF protein. The 
anti-PDGF aptamer is labeled with pyrene molecules at both ends. The open structure of the aptamer 
ensures that the pyrene molecules remain as monomers (emission peaks at ~400 nm). Upon binding to 
PDGF protein target, the aptamer adapts a close conformation, thus bringing the two pyrene molecules in 
close proximity. Consequently, pyrene excimers form and green light (~480 nm) is emitted after photo-
excitation.[49] [B] A schematic illustration of the FRET-based structure-switching signaling aptamer 
assay.[ref] Again, the structural arrangement of the aptamer upon target biding will result in the
displacement of the Q-DNA, which then restores the fluorescence signal stemming from the F-DNA.
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